Clinical Connection

A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

Sponsor: Seagen

Question 1 of 7

Have you been diagnosed with Hodgkin Lymphoma?